Table 2 Frequency of abnormal variables among the groups divided by eGFR*
From: Risk factors for chronic kidney disease in Japan: a community-based study
eGFR, mL/min/1.73 m2 | ||||
|---|---|---|---|---|
variables | 15--59 | 60--89 | ≥ 90 | p value |
Body mass index, % | ||||
≥ 25 kg/m2 | 22.3 | 21.5 | 15.3 | 0.032 |
HbA1c, % | ||||
>5.8% | 13.1 | 9.1 | 9.3 | 0.336 |
Serum choresterol level, % | ||||
>5.69 mmol/L (>220 mg/dL) | 30 | 23.1 | 13.4 | < 0.001 |
Serum triglyceride level, % | ||||
>1.69 mmol/L (>150 mg/dL) | 21.5 | 16.5 | 10.7 | < 0.001 |
Serum HDL choresterol level, % | ||||
<1.03 mmol/L (<40 mg/dL) | 12.3 | 11.3 | 7.9 | 0.151 |
AST, % | ||||
>40 U/L | 3.8 | 4.9 | 4.1 | 0.737 |
ALT, % | ||||
>40 U/L | 3.8 | 7.9 | 7.1 | 0.235 |
γ- GT, % | ||||
>60 U/L | 12.3 | 14.4 | 16.7 | 0.404 |
Blood pressure, % | ||||
Systoric ≥ 140 and diastoric ≥ 90 mmHg | 48.5 | 37.3 | 25.4 | < 0.001 |
U-ALB Ratio, % | ||||
>17.9 mg/g | 29.5 | 18.3 | 13.9 | < 0.001 |
U-Col4 Ratio, % | ||||
>8.2 (male), >9.4 (female) μg/g | 20.2 | 16.6 | 18 | 0.541 |